The HOBOE-2 multicenter randomized phase III trial in premenopausal patients with hormone-receptor positive early breast cancer comparing triptorelin plus either tamoxifen or letrozole or letrozole + zoledronic acid

F. Perrone, M. De Laurentiis, S. de Placido, M. Orditura, S. Cinieri, F. Riccardi, A. S. Ribecco, C. Putzu, L. Del Mastro, E. Rossi, B. Daniele, A. M. Mosconi, F. Di Rella, G. Landi, F. Nuzzo, C. Pacilio, R. Lauria, L. Arenare, M. C. Piccirillo, C. Gallo

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)viii704
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Publication statusPublished - Oct 1 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this